Compounds > trimetazidine
Page last updated: 2024-08-22

trimetazidine and Parkinson Disease, Secondary

trimetazidine has been researched along with Parkinson Disease, Secondary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andréjak, M; Gras, V; Masmoudi, K; Masson, H1
Martí Massó, JF1

Other Studies

3 other study(ies) available for trimetazidine and Parkinson Disease, Secondary

ArticleYear
Extrapyramidal adverse drug reactions associated with trimetazidine: a series of 21 cases.
    Fundamental & clinical pharmacology, 2012, Volume: 26, Issue:2

    Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Basal Ganglia Diseases; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Trimetazidine; Vasodilator Agents

2012
[Trimetazidine-induced parkinsonism].
    Neurologia (Barcelona, Spain), 2004, Volume: 19, Issue:7

    Topics: Aged; Aged, 80 and over; Female; Humans; Male; Parkinson Disease, Secondary; Trimetazidine

2004
Reversible Parkinsonism linked to trimetazidine (continued).
    Prescrire international, 2006, Volume: 15, Issue:84

    Topics: France; Humans; Parkinson Disease, Secondary; Treatment Outcome; Trimetazidine; Vasodilator Agents

2006